Injection Pen Market is forecast to reach $41.38 billion by 2022 from $30.97 billion in 2017 at a CAGR of 6.0% during (2017-2022) driven by rising prevalence of chronic diseases, favorable reimbursement scenario and government support and the increasing number of regulatory approvals resulting in the increased adoption amongst patients; while North America accounted for the largest share of the market followed by Europe in 2017. —
#Download Sample PDF with Browse 82 Market Data Tables and 40 Figures spread through 136 Pages and in-depth TOC on “Injection Pen Market - Global Forecast to 2022” Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1367552 .
The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F. Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland).
The North American injection pen market is expected to grow at the highest CAGR during the forecast period. North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American injection pen market is attributed to the rising prevalence of diabetes in the US and Canada, a favorable reimbursement scenario, and the increasing number of awareness programs in that region.
Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the large diabetic population and favorable reimbursements for diabetic treatments in developed countries. The diabetes segment is further segmented into Insulin and GLP-1.
Inquire for DISCOUNT on “Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and Region - Global Forecast to 2022” research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1367552 .
By type, the disposable injection pens segment in injection pen market is expected to grow at the highest rate during the forecast period (2017-2022). Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits that these pens offer, such as portability, ease of use, and a lower possibility of infection.
#Table of Content
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Injection Pen Market, By Type
7 Injection Pen Market, By Therapy
8 Injection Pen Market, By End User
9 Injection Pen Market, By Region
10 Competitive Landscape
11 Company Profiles
The injection pen market is segmented on the basis of end users into home care and hospital & clinics. The home care segment dominated the market on the basis of end users in 2017. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market to a certain extent.
Order a copy of “Injection Pen Market - Global Forecast to 2022” research report at http://www.reportsnreports.com/purchase.aspx?name=1367552 .
The report analyzes the injection pen market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
Break of primary participants was as mentioned below:
• By Company Type: Tier 1 - 50%, Tier 2 - 30% and Tier 3 - 20%
• By Designation: C-level - 30%, Director Level - 48%, Others - 22%
• By Region: North America - 48%, Europe - 20%, Asia-Pacific - 25%, Row - 7%
Email: Send Email
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Release ID: 474292